Study suggests way to improve treatment of hereditary breast cancer microbiologystudy
Generation of in-vivo talazoparib (PARPi)-response-and-progression Brca1-def and Bard1-def orthotopic models. Credit: EMBO Molecular Medicine (2024). DOI: 10.1038/s44321-024-00094-2 PARP inhibitors have […]